Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...

In a report released on March 21, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with ...

Investment analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Liquidia in a ...

An Oxford University spinout has secured £14 million in funding to advance its "transformative" AI imaging technology in healthcare.

In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on InflaRx (IFRX – Research Report). The company’s shares ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a £14M ($18M) Series C investment round. The round is co-led by prominent ...

Brainomix has developed Brainomix 360 Stroke, an AI-powered platform that analyses medical images to support stroke diagnosis and treatment.